Details

Autor(en) / Beteiligte

• Bohrer, Laura R
• Chaffee, Thomas S
• Chuntova, Pavlina
• Brady, Nicholas J
• Witschen, Patrice M
• Kemp, Sarah E
• Nelson, Andrew C
• Walcheck, Bruce
• Schwertfeger, Kathryn L

Titel

ADAM17 in tumor associated leukocytes regulates inflammatory mediators and promotes mammary tumor formation

Ist Teil von

• Genes & cancer, 2016-07, Vol.7 (7-8), p.240-253

Ort / Verlag

United States: Impact Journals LLC

Erscheinungsjahr

2016

Quelle

EZB Free E-Journals

Beschreibungen/Notizen

• The presence of inflammatory cells within the tumor microenvironment has been tightly linked to mammary tumor formation and progression. Specifically, interactions between tumor cells and infiltrating macrophages can contribute to the generation of a pro-tumorigenic microenvironment. Understanding the complex mechanisms that drive tumor cell-macrophage cross-talk will ultimately lead to the development of approaches to prevent or treat early stage breast cancers. As described here, we demonstrate that the cell surface protease a disintegrin and metalloproteinase 17 (ADAM17) is expressed by macrophages in mammary tumors and contributes to regulating the expression of pro-inflammatory mediators, including inflammatory cytokines and the inflammatory mediator cyclooxygenase-2 (Cox-2). Furthermore, we demonstrate that ADAM17 is expressed on leukocytes, including macrophages, within polyoma middle T (PyMT)-derived mammary tumors. Genetic deletion of ADAM17 in leukocytes resulted in decreased onset of mammary tumor growth, which was associated with reduced expression of the Cox-2 within the tumor. These findings demonstrate that ADAM17 regulates key inflammatory mediators in macrophages and that leukocyte-specific ADAM17 is an important promoter of mammary tumor initiation. Understanding the mechanisms associated with early stage tumorigenesis has implications for the development of preventive and/or treatment strategies for early stage breast cancers.